Lv2
108 积分 2023-05-05 加入
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy
12天前
已完结
A Self‐Assembled Protein Platform for Plug‐and‐Play Customization of Multivalent Artificial Antibodies and Antibody‐Drug Conjugates
24天前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
1个月前
已完结
Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a
1个月前
已完结
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials
2个月前
已完结
GLUTs-Facilitated Targeting BRD4 Degradation in Breast Cancer through Carbohydrate-Conjugated PROTACs
2个月前
已完结
MolT5-Linker: A Transformer-Based Sequence- and Putative Site-Guided Generative Framework for Antibody-Drug Conjugate Linkers
2个月前
已完结
High-payload antibody-oligonucleotide-drug conjugates (AODC) for targeted tumor chemo-immunotherapy
2个月前
已完结
New payloads drive next-gen antibody–drug conjugates
2个月前
已完结
Antibody-oligonucleotide conjugates in cancer therapy: Potential and Promise
3个月前
已完结
皖公网安备34019202002308
